tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools30% OFF!
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NVS Stock Latest News

Novartis says Phase III data confirm efficacy, safety of oral remibrutinib
The FlyNovartis says Phase III data confirm efficacy, safety of oral remibrutinib
2d ago
NVS
PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
PremiumThe Fly
PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
2d ago
AI
EW
Novartis initiated with a Buy at Goldman Sachs
PremiumThe Fly
Novartis initiated with a Buy at Goldman Sachs
2d ago
NVS
Novartis presents results from interim analysis of Phase III ALIGN study
PremiumThe Fly
Novartis presents results from interim analysis of Phase III ALIGN study
5d ago
NVS
Novartis presents latest Phase III Fabhalta data in C3 glomerulopathy
PremiumThe Fly
Novartis presents latest Phase III Fabhalta data in C3 glomerulopathy
5d ago
NVS
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe FlyJefferies healthcare analyst holds an analyst/industry conference call
8d ago
AZN
GSK
Novartis price target raised to CHF 77 from CHF 74 at Berenberg
PremiumThe Fly
Novartis price target raised to CHF 77 from CHF 74 at Berenberg
9d ago
NVS
Novartis meets all tender offer conditions to acquire MorphoSys
PremiumThe Fly
Novartis meets all tender offer conditions to acquire MorphoSys
16d ago
MOR
NVS
Novartis to present data from Phase 3 ASC4FIRST study at ASCO and EHA
PremiumThe Fly
Novartis to present data from Phase 3 ASC4FIRST study at ASCO and EHA
17d ago
NVS
H.C. Wainwright sees Actinium as buyout candidate after Mariana deal
PremiumThe Fly
H.C. Wainwright sees Actinium as buyout candidate after Mariana deal
30d ago
NVS
ATNM
Genmab reports Q1 revenue increased 46% vs. last year
PremiumThe Fly
Genmab reports Q1 revenue increased 46% vs. last year
30d ago
JNJ
NVS
FTC expands patent listing challenges for drugs
PremiumThe Fly
FTC expands patent listing challenges for drugs
1M ago
AZN
BMY
Biotech Sector: M&A Fuels Renewed Excitement
PremiumMarket NewsBiotech Sector: M&A Fuels Renewed Excitement
1M ago
NVS
XBI
Novartis price target raised to CHF 108 from CHF 104 at UBS
PremiumThe Fly
Novartis price target raised to CHF 108 from CHF 104 at UBS
1M ago
NVS
Novartis price target raised to CHF 95 from CHF 90 at JPMorgan
PremiumThe Fly
Novartis price target raised to CHF 95 from CHF 90 at JPMorgan
1M ago
NVS
BeiGene price target raised to $236 from $235 at TD Cowen
PremiumThe Fly
BeiGene price target raised to $236 from $235 at TD Cowen
1M ago
NVS
BGNE
Novartis, MMV announce data for Phase II/III CALINA study of Coartem
PremiumThe Fly
Novartis, MMV announce data for Phase II/III CALINA study of Coartem
1M ago
NVS
Novartis reports FDA approves Lutathera for pediatric GEP-NETs
PremiumThe Fly
Novartis reports FDA approves Lutathera for pediatric GEP-NETs
1M ago
NVS
Novartis Q1 Results Surge, 2024 Outlook Brightens
PremiumCompany Announcements
Novartis Q1 Results Surge, 2024 Outlook Brightens
1M ago
6K
NVS
Novartis FY24 net sales, core operating income guidance raised
PremiumThe FlyNovartis FY24 net sales, core operating income guidance raised
1M ago
NVS
Novartis reports Q1 core EPS grew 23% in constant currency to $1.80
PremiumThe Fly
Novartis reports Q1 core EPS grew 23% in constant currency to $1.80
1M ago
NVS
NVS Earnings: Novartis Beats Q1 Estimates, Raises Outlook
PremiumMarket News
NVS Earnings: Novartis Beats Q1 Estimates, Raises Outlook
1M ago
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >